Published in N Engl J Med on November 04, 1993
Impact of screening versus symptomatic measurement of deep vein thrombosis in a national quality improvement registry. J Vasc Surg (2012) 1.63
Iliac vein stenting for chronic venous insufficiency. Tex Heart Inst J (2007) 0.99
Pharmacokinetics and pharmacodynamics of oral heparin solid dosage form in healthy human subjects. J Clin Pharmacol (2007) 0.94
Thromboprophylaxis in surgical patients. Can J Surg (2003) 0.91
Thromboprophylaxis with apixaban and the risk of pulmonary embolism in patients undergoing knee replacement surgery. J Community Hosp Intern Med Perspect (2015) 0.79
Antithrombotic prophylaxis in major orthopaedic surgery: an historical overview and update of current recommendations. Int Orthop (2013) 0.78
Thromboprophylaxis and orthopaedic surgery: options and current guidelines. Malays J Med Sci (2014) 0.78
Surgical site infections and other postoperative complications following prophylactic anticoagulation in total joint arthroplasty. PLoS One (2014) 0.77
Bleeding Complications to Long-Term Oral Anticoagulant Therapy. J Thromb Thrombolysis (1994) 0.76
Comparative safety and efficacy of antithrombotics in the management of venous thromboembolism after knee or hip replacement surgery: focus on rivaroxaban. Clin Pharmacol (2013) 0.76
Venous Thromboembolism (VTE) Prophylaxis for Hip and Knee Arthroplasty: Changing Trends. Curr Rev Musculoskelet Med (2014) 0.75
The relationship of the factor V Leiden mutation or the deletion-deletion polymorphism of the angiotensin converting enzyme to postoperative thromboembolic events following total joint arthroplasty. BMC Musculoskelet Disord (2001) 0.75
Low-molecular-weight heparin vs. warfarin for prophylaxis against deep-vein thrombosis. N Engl J Med (1994) 0.75
Low-molecular-weight heparin vs. warfarin for prophylaxis against deep-vein thrombosis. N Engl J Med (1994) 0.75
The diagnosis and treatment of deep-vein thrombosis. N Engl J Med (1993) 0.75
Comparison of 3,000 and 5,000 IU aXa/day certoparin in the prevention of deep-vein thrombosis after total hip replacement. Thromb J (2012) 0.75
Duplex Ultrasonography Has Limited Utility in Detection of Postoperative DVT After Primary Total Joint Arthroplasty. HSS J (2016) 0.75
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature (1995) 11.89
THE ELECTROCARDIOGRAM OF THE STOKES-ADAMS ATTACK. Br Heart J (1941) 9.39
Stages of change and decisional balance for 12 problem behaviors. Health Psychol (1994) 9.28
THE GRADIENT OF VASCULAR PERMEABILITY. J Exp Med (1930) 7.03
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med (1999) 5.14
A survey of 215 non-hemophilic patients with inhibitors to Factor VIII. Thromb Haemost (1981) 4.39
Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain. EMBO J (1998) 4.14
THE GRADIENT OF VASCULAR PERMEABILITY : III. THE GRADIENT ALONG THE CAPILLARIES AND VENULES OF FROG SKIN. J Exp Med (1931) 4.07
Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med (2003) 3.94
Sexual health of teenagers in England and Wales: analysis of national data. BMJ (1999) 3.54
Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. J Natl Cancer Inst Monogr (1999) 3.45
Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism. Consideration of noninvasive management. Ann Intern Med (1994) 3.44
A clinician's guide for conducting randomized trials in individual patients. CMAJ (1988) 3.35
Cerebral perfusion deficits in dysbaric illness. Lancet (1989) 3.31
Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci U S A (1997) 3.30
Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med (1992) 3.23
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med (1982) 3.16
Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem (2000) 3.12
Assessing the impact of national anti-HIV sexual health campaigns: trends in the transmission of HIV and other sexually transmitted infections in England. Sex Transm Infect (2001) 3.09
The genome of the simian and human malaria parasite Plasmodium knowlesi. Nature (2008) 3.02
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med (1986) 3.00
The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience. Ann Intern Med (1990) 2.89
Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation (1997) 2.80
Distribution, diversity, and host specificity of Bartonella in rodents from the Southeastern United States. Am J Trop Med Hyg (1997) 2.77
Hemorrhagic complications of anticoagulant treatment. Chest (2001) 2.76
From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis. Biotechnology (N Y) (1996) 2.75
Use of human patient simulation to teach emergency medicine trainees advanced airway skills. J Accid Emerg Med (1999) 2.72
Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell (1996) 2.66
Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med (1990) 2.63
Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med (1997) 2.59
Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma. Ann Oncol (1998) 2.57
Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisone therapy. Br Med J (1968) 2.52
The Mosoriot medical record system: design and initial implementation of an outpatient electronic record system in rural Kenya. Int J Med Inform (2000) 2.52
Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin. Br J Pharmacol (1992) 2.50
Genitourinary medicine services in the United Kingdom are failing to meet current demand. Int J STD AIDS (2001) 2.47
Purification of an exo-beta-D-(1 bonded to 3)-glucanase from Basidiomycete species QM 806. J Biol Chem (1968) 2.30
Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J (1997) 2.28
The Fulminant Form of Epidemic Hepatitis. Am J Pathol (1946) 2.27
Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial. J Clin Oncol (2001) 2.16
Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group. Neurology (1996) 2.13
Decedents' reported preferences for physician-assisted death: a survey of informants listed on death certificates in Utah. J Clin Ethics (1995) 2.10
Proceedings: A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh (1975) 2.10
Innovative method for carbon dioxide determination in human postmortem cardiac gas samples using headspace-gas chromatography-mass spectrometry and stable labeled isotope as internal standard. Anal Chim Acta (2013) 2.06
Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies. Sex Transm Infect (2004) 2.05
Improved analysis of brachial artery ultrasound using a novel edge-detection software system. J Appl Physiol (1985) (2001) 2.02
Nasal Medication in Sinusitis. Can Med Assoc J (1945) 2.01
Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases. Ann Intern Med (1998) 1.98
Evaluation of prenatal care information on birth certificates. Paediatr Perinat Epidemiol (1997) 1.97
The effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetes. J Am Coll Cardiol (2001) 1.95
Second malignant neoplasms in children: an update from the Late Effects Study Group. J Clin Oncol (1985) 1.95
5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer. Ann Intern Med (1980) 1.95
Expression of an antimicrobial peptide via the chloroplast genome to control phytopathogenic bacteria and fungi. Plant Physiol (2001) 1.93
Pitfalls in the evaluation of ablative therapy for telangiectases. Dermatol Surg (1998) 1.91
Mesenteric venous thrombosis. J Vasc Surg (1989) 1.86
Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab (2000) 1.85
Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J Hepatol (1998) 1.84
Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease. J Lab Clin Med (1999) 1.82
Kinetics of the human renin and human substrate reaction. Cardiovasc Res (1971) 1.75
Protein expression profiles in human breast ductal carcinoma and histologically normal tissue. Electrophoresis (1997) 1.74
Trends in HIV testing and recording of HIV status in the UK primary care setting: a retrospective cohort study 1995-2005. Sex Transm Infect (2009) 1.74
The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement. J Thromb Haemost (2007) 1.73
Pten (phosphatase and tensin homologue gene) haploinsufficiency promotes insulin hypersensitivity. Diabetologia (2006) 1.72
Systemic lupus erythematosus in migrants from west Africa compared with Afro-Caribbean people in the UK. Lancet (2001) 1.69
Biogeography and ecological setting of Indian Ocean hydrothermal vents. Science (2001) 1.69
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Skeletal muscle enzymes and fiber composition in male and female track athletes. J Appl Physiol (1976) 1.66
A polyclonal outbreak of predominantly VanB vancomycin-resistant enterococci in northeast Ohio. Northeast Ohio Vancomycin-Resistant Enterococcus Surveillance Program. Clin Infect Dis (1999) 1.64
Factors associated with exacerbation of heart failure include treatment adherence and health literacy skills. Clin Pharmacol Ther (2009) 1.63
Rapid increase in gonorrhoea and syphilis diagnoses in England in 2011. Euro Surveill (2012) 1.62
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Effects of elevated plasma FFA and insulin on muscle glycogen usage during exercise. J Appl Physiol Respir Environ Exerc Physiol (1977) 1.59
Reduced cardiac selenium content in the acquired immunodeficiency syndrome. JPEN J Parenter Enteral Nutr (1990) 1.59
Frailty and sarcopenia: definitions and outcome parameters. Osteoporos Int (2012) 1.58
Epidemiology. Foot-and-mouth disease under control in the UK. Nature (2001) 1.57
The impact of re-engineering and other cost reduction strategies on the staff of a large teaching hospital: a longitudinal study. Med Care (1999) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities. The Genital Ulcer Disease Surveillance Group. J Infect Dis (1998) 1.55
An integrated assessment framework for climate change and infectious diseases. Environ Health Perspect (1999) 1.54
Pulmonary function and cardiovascular risk factor relationships in black and in white young men and women. The CARDIA Study. Chest (1991) 1.54
Indocyanine green clearance as a test for hepatic function. Evaluation by dichromatic ear densitometry. JAMA (1967) 1.54
HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA. Ann Rheum Dis (1992) 1.52
Managing acute anaphylaxis. New guidelines emphasise importance of intramuscular adrenaline. BMJ (1999) 1.52
Oncology Rehabilitation Program at the Ottawa Regional Cancer Centre: program description. CMAJ (1999) 1.51
Quantitation and origin of the mitochondrial membrane potential in human cells lacking mitochondrial DNA. Eur J Biochem (1999) 1.51
AFP-L3: a new generation of tumor marker for hepatocellular carcinoma. Clin Chim Acta (2001) 1.51
The role of cerebral oximetry in combination with awake testing in patients undergoing carotid endarterectomy under local anaesthesia. Eur J Vasc Endovasc Surg (2011) 1.50
Clinical importance of pharmacist-obtained medication histories using a validated questionnaire. Am J Hosp Pharm (1984) 1.50
Accident and emergency doctors lack proper training in trauma. BMJ (1995) 1.49
Compliance with an allergen immunotherapy regime. Ann Allergy Asthma Immunol (1995) 1.48
Acquired hemophilia. Rev Clin Exp Hematol (2001) 1.48
Why fisheries collapse and what to do about it. Proc Natl Acad Sci U S A (1996) 1.47
Amygdala and ventral anterior cingulate activation predicts treatment response to cognitive behaviour therapy for post-traumatic stress disorder. Psychol Med (2007) 1.46
Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study. J Thromb Haemost (2006) 1.46
Point mutations regarded as missense mutations cause splicing defects in the factor XI gene. J Thromb Haemost (2011) 1.46
Amyloidosis in association with human immunodeficiency virus infection. Clin Infect Dis (1992) 1.45
Capillaroscopic observations in rheumatic diseases. Ann Rheum Dis (1970) 1.45
Histiocytic necrotizing lymphadenitis, Kikuchi-Fujimoto's disease, associated with systemic lupus erythemotosus. QJM (1997) 1.45
Safety and feasibility of an insulin adjustment protocol to maintain blood glucose concentrations within a narrow range in critically ill patients in an Australian level III adult intensive care unit. Crit Care Resusc (2004) 1.44